Juan Martin‐Liberal
Author
Alternate names Juan Martin‐Liberal, J. Martin‐Liberal, J. Martín‐Liberal, Juan Martín‐Liberal
Institution Institut Català d'Oncologia
Past institutions Institut Català d'Oncologia, Institut Català d'Ornitologia, Duran i Reynals Hospital, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology +5 more
ORCID: Yes
H-index: 22
I10-index: 49
Works count: 222
Citations count: 2,418
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
2016 · Stefan Diem, Benjamin Kasenda, et al. · British Journal of Cancer
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial
2019 · Roy S. Herbst, Hendrik‐Tobias Arkenau, et al. · The Lancet Oncology
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)
2018 · Hendrik‐Tobias Arkenau, Juan Martin‐Liberal, et al. · The Oncologist